Literature DB >> 19918946

Preparation of stable single-chain trimers engineered with peptide, beta2 microglobulin, and MHC heavy chain.

Ted Hansen1, Y Y Lawrence Yu, Daved H Fremont.   

Abstract

This unit describes a method for constructing a class I MHC molecule with a bound peptide as a single polypeptide chain, termed SCT, for single chain trimer. The component organization of the SCT appears to be widely applicable to different mouse or human MHC class I isotypes bound by different antigenic peptides. The enhanced peptide occupancy afforded by the SCT format makes these molecules effective reagents as DNA vaccines, multimeric staining reagents to enumerate CD8 T cells, and probes of lymphocyte biology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19918946     DOI: 10.1002/0471142735.im1705s87

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  15 in total

1.  Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.

Authors:  Sojung Kim; Adam Zuiani; Javier A Carrero; Ted H Hansen
Journal:  Vaccine       Date:  2012-01-26       Impact factor: 3.641

2.  Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination.

Authors:  Lijin Li; Sojung Kim; John M Herndon; Peter Goedegebuure; Brian A Belt; Ansuman T Satpathy; Timothy P Fleming; Ted H Hansen; Kenneth M Murphy; William E Gillanders
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

3.  MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Authors:  Mollie M Jurewicz; Richard A Willis; Vasanthi Ramachandiran; John D Altman; Lawrence J Stern
Journal:  Anal Biochem       Date:  2019-06-13       Impact factor: 3.365

4.  Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.

Authors:  Sojung Kim; Lijin Li; Curtis P McMurtrey; William H Hildebrand; Jon A Weidanz; William E Gillanders; Michael S Diamond; Ted H Hansen
Journal:  J Immunol       Date:  2010-03-08       Impact factor: 5.422

Review 5.  Basic and translational applications of engineered MHC class I proteins.

Authors:  Ted H Hansen; Janet M Connolly; Keith G Gould; Daved H Fremont
Journal:  Trends Immunol       Date:  2010-09-09       Impact factor: 16.687

6.  Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance.

Authors:  Zhentao Yang; Yan Wang; Sixue Liu; Weixian Deng; Shirley H Lomeli; Gatien Moriceau; James Wohlschlegel; Marco Piva; Roger S Lo
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

7.  Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines.

Authors:  Amanda L Wooster; Trevor S Anderson; Devin B Lowe
Journal:  J Immunol Methods       Date:  2018-10-19       Impact factor: 2.303

8.  Production of Class II MHC Proteins in Lentiviral Vector-Transduced HEK-293T Cells for Tetramer Staining Reagents.

Authors:  Richard A Willis; Vasanthi Ramachandiran; John C Shires; Ge Bai; Kelly Jeter; Donielle L Bell; Lixia Han; Tamara Kazarian; Kyla C Ugwu; Oskar Laur; Susana Contreras-Alcantara; Dale L Long; John D Altman
Journal:  Curr Protoc       Date:  2021-02

9.  Domain-swapped T cell receptors improve the safety of TCR gene therapy.

Authors:  Michael T Bethune; Marvin H Gee; Mario Bunse; Mark S Lee; Eric H Gschweng; Meghana S Pagadala; Jing Zhou; Donghui Cheng; James R Heath; Donald B Kohn; Michael S Kuhns; Wolfgang Uckert; David Baltimore
Journal:  Elife       Date:  2016-11-08       Impact factor: 8.140

10.  Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes.

Authors:  Marvin H Gee; Arnold Han; Shane M Lofgren; John F Beausang; Juan L Mendoza; Michael E Birnbaum; Michael T Bethune; Suzanne Fischer; Xinbo Yang; Raquel Gomez-Eerland; David B Bingham; Leah V Sibener; Ricardo A Fernandes; Andrew Velasco; David Baltimore; Ton N Schumacher; Purvesh Khatri; Stephen R Quake; Mark M Davis; K Christopher Garcia
Journal:  Cell       Date:  2017-12-21       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.